POLARISQB New SaaS, Quantum-Aided Drug Design (QuADD) Demonstrates Advantage Versus Traditional Library Builds
. Once a druggable protein target is identified, it becomes a race to discover a preclinical drug candidate for the project. One of the slowest steps in drug discovery is generating a diverse library of starting candidates. In the past, these libraries have been limited to generic options that are not specific to the protein…